British tennis star Emma Raducanu is set to make her long-awaited return to action in Strasbourg, having been granted a wildcard entry into the tournament. The 20-year-old has not competed since her first-round exit at the Australian Open in January, and will use the Strasbourg event as crucial match practice ahead of the French Open.
Raducanu's decision to compete in Strasbourg has been welcomed by fans and pundits alike, who are eager to see the talented young player back in action. The tournament, which takes place from 23-29 May, is a key preparation event for the French Open, which begins on 28 May.
Raducanu has endured a challenging period since her surprise victory at the 2021 US Open, struggling with injuries and form. However, she has shown promising signs of a return to top form in recent weeks, and will be hoping to build on this momentum in Strasbourg.
Competing in Strasbourg will provide Raducanu with invaluable match practice ahead of the French Open, where she will be eager to make a deep run. The British tennis star has already shown her ability to compete at the highest level, and will be looking to use the Strasbourg event as a springboard for success in Paris.
Raducanu to make return with wildcard in Strasbourg
UKPulse Sport DeskBritish tennis star Emma Raducanu is set to make her long-awaited return to action in Strasbourg, having been granted a wildcard entry. She will use the tournament as crucial match practice ahead of the French Open.
- Emma Raducanu has been granted a wildcard entry into the Strasbourg tournament
- The British tennis star is seeking match practice ahead of the French Open
- Raducanu will make her return to action after a period of absence
Why this matters: Emma Raducanu's return to action is a major talking point in the tennis world, with fans eager to see the British star back in competition.
What this means for you: This story may affect fans, fixtures, club plans or broadcast schedules. Supporters should check official club and competition updates for the latest confirmed information.